Granite Investment Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-216,883	Closed	-$7.85M	–	276
2025 Q1	$7.85M	Buy	216,883 +56,468	+35%	+$2.04M	0.4%	88
2024 Q4	$6.75M	Sell	160,415 -14,611	-8%	-$615K	0.29%	101
2024 Q3	$9.72M	Buy	+175,026	New	+$9.72M	0.42%	87